A controversy has arisen concerning the treatment of young people with gender dysphoria, as there are questions about the efficacy of utilizing puberty blockers and cross-sex hormones. The Gender Identity Development Service (GIDS) in the UK has faced scrutiny after it was revealed that the majority of young people referred to their clinic ended up taking cross-sex hormones, with clinicians questioning the quality of assessments that led to these prescriptions.